• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群失调与肠易激综合征:益生菌的潜在作用。

Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.

机构信息

Università degli Studi di Milano, Milan, Italy.

Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy.

出版信息

J Infect. 2018 Feb;76(2):111-120. doi: 10.1016/j.jinf.2017.12.013. Epub 2017 Dec 29.

DOI:10.1016/j.jinf.2017.12.013
PMID:29291933
Abstract

OBJECTIVE

To discuss the role of gut dysbiosis in the development of irritable bowel syndrome (IBS) and the impact of probiotics as a potential therapeutic measure.

METHODS

PubMed was used to search for all of the studies published over the last 15 years using the key words: "irritable bowel syndrome" and "gut dysbiosis" or "probiotic". More than 800 articles were found, but only those published in English or providing evidence-based data were included in the evaluation.

RESULTS

IBS is a common disease for which no resolutive therapy is presently available. In recent years, strong evidence of a possible relationship between modifications of the gut microbiota composition and development of IBS has been collected. Moreover, the evidence showed that attempts to treat acute infectious and post-antibiotic gastroenteritis with some probiotics were significantly effective in a great number of patients, leading many experts to suggest the use of probiotics to address all of the clinical problems associated with IBS.

CONCLUSION

The available data are promising, but presently, a precise definition of which probiotic or which mixture of probiotics is effective cannot be made. Moreover, the dose and duration of treatment has not been established. Finally, we do not know whether probiotic treatment should be different according to the type of IBS. Further studies are needed before probiotics can be considered a reliable treatment for IBS.

摘要

目的

探讨肠道菌群失调在肠易激综合征(IBS)发展中的作用,以及益生菌作为一种潜在治疗手段的影响。

方法

通过使用关键词“irritable bowel syndrome”和“gut dysbiosis”或“probiotic”,在 PubMed 上搜索过去 15 年发表的所有研究。共找到 800 多篇文章,但仅纳入评估中发表英文文献或提供循证数据的文献。

结果

IBS 是一种常见疾病,目前尚无根治方法。近年来,人们收集到了大量关于肠道微生物群落组成改变与 IBS 发展之间可能存在关联的证据。此外,有证据表明,尝试使用某些益生菌治疗急性感染性和抗生素相关性胃肠炎在大量患者中非常有效,这促使许多专家建议使用益生菌来解决与 IBS 相关的所有临床问题。

结论

现有数据很有前景,但目前尚无法明确哪种益生菌或哪种益生菌混合物有效。此外,治疗的剂量和持续时间尚未确定。最后,我们不知道益生菌治疗是否应根据 IBS 的类型而有所不同。在益生菌被认为是 IBS 的可靠治疗方法之前,还需要进一步的研究。

相似文献

1
Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.肠道菌群失调与肠易激综合征:益生菌的潜在作用。
J Infect. 2018 Feb;76(2):111-120. doi: 10.1016/j.jinf.2017.12.013. Epub 2017 Dec 29.
2
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.肠道微生物群的调节:聚焦于肠易激综合征的治疗
Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13.
3
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.综述文章:肠道微生物群在肠易激综合征中的作用及其对治疗靶点的潜在影响的证据。
Aliment Pharmacol Ther. 2014 May;39(10):1033-42. doi: 10.1111/apt.12728. Epub 2014 Mar 25.
4
Is irritable bowel syndrome an infectious disease?肠易激综合征是一种传染病吗?
World J Gastroenterol. 2016 Jan 28;22(4):1331-4. doi: 10.3748/wjg.v22.i4.1331.
5
Gut microbiota, dysbiosis and colon lavage.肠道微生物群、失调和结肠灌洗。
Dig Liver Dis. 2019 Sep;51(9):1209-1213. doi: 10.1016/j.dld.2019.06.012. Epub 2019 Jul 27.
6
Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.肠道微生物群与肠易激综合征中菌群失调的治疗方法:最新进展与未来展望。
Turk J Med Sci. 2020 Nov 3;50(SI-2):1632-1641. doi: 10.3906/sag-2002-57.
7
British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).英国饮食协会对成人肠易激综合征管理中使用益生菌的系统评价的系统评价及循证实践指南(2016年更新)
J Hum Nutr Diet. 2016 Oct;29(5):576-92. doi: 10.1111/jhn.12386. Epub 2016 Jun 6.
8
Fecal microbiota transplantation for managing irritable bowel syndrome.粪便微生物群移植治疗肠易激综合征。
Expert Rev Gastroenterol Hepatol. 2018 May;12(5):439-445. doi: 10.1080/17474124.2018.1447380. Epub 2018 Mar 8.
9
The gut microbiome and irritable bowel syndrome: State of art review.肠道微生物群与肠易激综合征:现状综述
Arab J Gastroenterol. 2018 Sep;19(3):136-141. doi: 10.1016/j.ajg.2018.02.008. Epub 2018 Jun 20.
10
Dysbiosis in Irritable Bowel Syndrome.肠易激综合征中的生态失调。
J Assoc Physicians India. 2023 Sep;71(9):75-81. doi: 10.59556/japi.71.0353.

引用本文的文献

1
The microbiota-gut-brain-axis theory: role of gut microbiota modulators (GMMs) in gastrointestinal, neurological, and mental health disorders.微生物群-肠道-脑轴理论:肠道微生物群调节剂(GMMs)在胃肠道、神经和精神疾病中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 5. doi: 10.1007/s00210-025-04155-2.
2
Could the Therapeutic Effect of Physical Activity on Irritable Bowel Syndrome Be Mediated Through Changes to the Gut Microbiome? A Narrative and Hypothesis Generating Review.体育活动对肠易激综合征的治疗作用是否可通过肠道微生物群的变化介导?一项叙述性及提出假设的综述
Neurogastroenterol Motil. 2025 Jun;37(6):e70004. doi: 10.1111/nmo.70004. Epub 2025 Mar 3.
3
Efficacy of fermented foods in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
发酵食品对肠易激综合征的疗效:随机对照试验的系统评价和荟萃分析
Front Nutr. 2025 Jan 7;11:1494118. doi: 10.3389/fnut.2024.1494118. eCollection 2024.
4
Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review.Toll样受体4在肠易激综合征中起关键作用:一项范围综述
Front Immunol. 2024 Dec 19;15:1490653. doi: 10.3389/fimmu.2024.1490653. eCollection 2024.
5
Pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections: a delphi study and consensus document about definition, diagnostic criteria, treatment and follow-up.儿科急性发作的神经精神综合征和与链球菌感染相关的儿科自身免疫性神经精神障碍:关于定义、诊断标准、治疗和随访的德尔菲研究和共识文件。
Front Immunol. 2024 Oct 24;15:1420663. doi: 10.3389/fimmu.2024.1420663. eCollection 2024.
6
A Synbiotic Combining Chitin-Glucan and NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS.一种包含几丁质-葡聚糖和 NCFM 的合生菌可诱导 IBS 动物模型的结肠分子特征,从而舒缓肠道疼痛和炎症。
Int J Mol Sci. 2024 Oct 5;25(19):10732. doi: 10.3390/ijms251910732.
7
Development and validation of a PMA-qPCR method for accurate quantification of viable in probiotics.一种用于准确量化益生菌中活菌的PMA-qPCR方法的开发与验证。
Front Microbiol. 2024 Aug 7;15:1456274. doi: 10.3389/fmicb.2024.1456274. eCollection 2024.
8
N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine induces endothelium-dependent hyperpolarization-mediated vasorelaxation via store-operated calcium entry mechanism in healthy and intestinal inflammatory mice.N,N,N',N'-四(2-吡啶甲基)乙二胺通过储存操纵性钙内流机制在健康和肠道炎症小鼠中诱导内皮依赖性超极化介导的血管舒张。
Heliyon. 2024 Jul 6;10(14):e33994. doi: 10.1016/j.heliyon.2024.e33994. eCollection 2024 Jul 30.
9
A novel Bacillus aerolatus CX253 attenuates inflammation induced by Streptococcus pneumoniae in childhood and pregnant rats by regulating gut microbiome.一株新型 Aerolatus 芽孢杆菌 CX253 通过调节肠道微生物组减轻儿童和孕鼠肺炎链球菌引起的炎症。
Cell Mol Life Sci. 2024 Jul 29;81(1):319. doi: 10.1007/s00018-024-05232-0.
10
Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea.基于网络药理学及实验验证探讨肠安方治疗腹泻型肠易激综合征的作用机制
Heliyon. 2024 Jun 17;10(12):e33102. doi: 10.1016/j.heliyon.2024.e33102. eCollection 2024 Jun 30.